Literature DB >> 20727858

microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.

Lin Liu1, Lin Chen, Yingxin Xu, Rong Li, Xiaohui Du.   

Abstract

Deregulated microRNAs and their roles in cancer development have attracted much attention. In the present study, we analyzed the roles of miR-195 in colorectal cancer pathogenesis, as its participation in some other types of cancer has been suggested by previous reports. By comparing miR-195 expression in 81 human colorectal cancer tissues and matched non-neoplastic mucosa tissues, we found that miR-195 was downregulated in cancer tissues. And restoration of miR-195 in colorectal cancer cell lines HT29 and LoVo could reduce cell viability, promote cell apoptosis and suppress tumorigenicity. Moreover, important antiapoptotic Bcl-2 was identified to be directly targeted by miR-195, and miR-195 was further suggested to exert its proapoptotic function mainly through targeting Bcl-2 expression. Taken together, our study provides important roles of miR-195 in colorectal cancer pathogenesis and implicates its potential application in cancer therapy.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727858     DOI: 10.1016/j.bbrc.2010.08.046

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  97 in total

Review 1.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

2.  MicroRNA-630 is a prognostic marker for patients with colorectal cancer.

Authors:  Dake Chu; Jianyong Zheng; Jipeng Li; Yunming Li; Jian Zhang; Qingchuan Zhao; Weizhong Wang; Gang Ji
Journal:  Tumour Biol       Date:  2014-07-01

3.  Study on the molecular regulatory mechanism of MicroRNA-195 in the invasion and metastasis of colorectal carcinoma.

Authors:  Bin Yang; Zhigang Tan; Yan Song
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.

Authors:  Dong Zheng; Jian Ma; Yong Yu; Minghui Li; Rui Ni; Grace Wang; Ruizhen Chen; Jianmin Li; Guo-Chang Fan; James C Lacefield; Tianqing Peng
Journal:  Diabetologia       Date:  2015-05-21       Impact factor: 10.122

5.  MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a.

Authors:  Ning Wang; Heng Wei; Duo Yin; Yanming Lu; Yao Zhang; Qiao Zhang; Xiaoxin Ma; Shulan Zhang
Journal:  Tumour Biol       Date:  2015-10-28

6.  Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.

Authors:  Fu-long Zhao; Yue-chao Dou; Xue-fei Wang; Da-cheng Han; Zhen-gang Lv; Shuang-lei Ge; Ya-kui Zhang
Journal:  Mol Biol Rep       Date:  2014-08-08       Impact factor: 2.316

7.  Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.

Authors:  Lyndsay V Rhodes; Syreeta L Tilghman; Stephen M Boue; Shuchun Wang; Hafez Khalili; Shannon E Muir; Melyssa R Bratton; Qiang Zhang; Guangdi Wang; Matthew E Burow; Bridgette M Collins-Burow
Journal:  Oncol Lett       Date:  2011-10-24       Impact factor: 2.967

8.  MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion.

Authors:  Qian-Qian Zhang; Hui Xu; Mian-Bo Huang; Li-Ming Ma; Qiao-Juan Huang; Qing Yao; Hui Zhou; Liang-Hu Qu
Journal:  Neuro Oncol       Date:  2012-01-04       Impact factor: 12.300

9.  MiR-195 suppresses colon cancer proliferation and metastasis by targeting WNT3A.

Authors:  Baoyu Li; Shunsheng Wang; Shumei Wang
Journal:  Mol Genet Genomics       Date:  2018-06-09       Impact factor: 3.291

10.  The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.

Authors:  Xiaojun Li; Chunyan Yang; Xiaoqiang Wang; Jian Zhang; Ruipeng Zhang; Ruiting Liu
Journal:  Med Oncol       Date:  2013-11-29       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.